Microbio Co., Ltd. (TPEX:4128)

Microbio Statistics

Total Valuation

Microbio has a market cap or net worth of TWD 10.09 billion. The enterprise value is 9.42 billion.

Market Cap	10.09B
Enterprise Value	9.42B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Microbio has 588.17 million shares outstanding.

Current Share Class	588.17M
Shares Outstanding	588.17M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	3.17%
Float	433.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.33
PB Ratio	0.99
P/TBV Ratio	1.15
P/FCF Ratio	411.97
P/OCF Ratio	118.29
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.43
EV / Sales	4.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	384.53

Financial Position

The company has a current ratio of 4.30, with a Debt / Equity ratio of 0.07.

Current Ratio	4.30
Quick Ratio	3.77
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	27.25
Interest Coverage	-34.72

Financial Efficiency

Return on equity (ROE) is -8.64% and return on invested capital (ROIC) is -4.88%.

Return on Equity (ROE)	-8.64%
Return on Assets (ROA)	-1.94%
Return on Invested Capital (ROIC)	-4.88%
Return on Capital Employed (ROCE)	-3.53%
Weighted Average Cost of Capital (WACC)	7.22%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.14
Inventory Turnover	4.72

Taxes

In the past 12 months, Microbio has paid 1.96 million in taxes.

Income Tax	1.96M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.28% in the last 52 weeks. The beta is 0.61, so Microbio's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-24.28%
50-Day Moving Average	17.96
200-Day Moving Average	21.18
Relative Strength Index (RSI)	47.54
Average Volume (20 Days)	1,421,226

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Microbio had revenue of TWD 1.89 billion and -757.75 million in losses. Loss per share was -1.29.

Revenue	1.89B
Gross Profit	753.46M
Operating Income	-407.11M
Pretax Income	-951.58M
Net Income	-757.75M
EBITDA	-310.32M
EBIT	-407.11M
Loss Per Share	-1.29

Balance Sheet

The company has 2.63 billion in cash and 667.20 million in debt, with a net cash position of 1.96 billion or 3.34 per share.

Cash & Cash Equivalents	2.63B
Total Debt	667.20M
Net Cash	1.96B
Net Cash Per Share	3.34
Equity (Book Value)	10.20B
Book Value Per Share	15.15
Working Capital	2.61B

Cash Flow

In the last 12 months, operating cash flow was 85.27 million and capital expenditures -60.79 million, giving a free cash flow of 24.49 million.

Operating Cash Flow	85.27M
Capital Expenditures	-60.79M
Depreciation & Amortization	96.80M
Net Borrowing	-161.28M
Free Cash Flow	24.49M
FCF Per Share	0.04

Margins

Gross margin is 39.78%, with operating and profit margins of -21.49% and -40.01%.

Gross Margin	39.78%
Operating Margin	-21.49%
Pretax Margin	-50.24%
Profit Margin	-40.01%
EBITDA Margin	-16.38%
EBIT Margin	-21.49%
FCF Margin	1.29%

Dividends & Yields

Microbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.51%
FCF Yield	0.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 29, 2024. It was a forward split with a ratio of 1.049999998.

Last Split Date	Aug 29, 2024
Split Type	Forward
Split Ratio	1.049999998

Scores

Microbio has an Altman Z-Score of 4.33 and a Piotroski F-Score of 4.

Altman Z-Score	4.33
Piotroski F-Score	4